Cystinosis requires lifelong cystine-depleting therapy; however, currently approved cysteamine products, Cystagon® and Procysbi®, are associated with frequent dosing, gastrointestinal intolerance, and ...

The MarketWatch News Department was not involved in the creation of this content.-- Servier reported Group revenues of EUR6.9 billion for 2024/25, up 16.2% from 2023/24. -- Growth ...

H.C. Wainwright said KRRO-121 adds a second, "independently risk-mitigated asset as a call option." ・Piper Sandler said it ...

The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) ...

In order for heart and vascular cells to develop properly and remain healthy for a long time, many processes in the cells must interact precisely. A new study from the German Center for Cardiovascular ...

A long-term study found that while a ketogenic diet prevented weight gain, it also triggered major metabolic problems. Mice developed fatty liver disease, abnormal blood fats, and an impaired ability ...

The largest study of its kind from the Boston University CTE Center reveals that chronic traumatic encephalopathy (CTE) ...

Thiogenesis Therapeutics, Corp. (TSXV: TTI) (OTCQX: TTIPF) ("Thiogenesis" or the "Company"), a clinical-stage biotechnology company developing ...

A new study has found that MET (hepatocyte growth factor receptor) signaling plays a critical protective role in acetaminophen-induced acute liver failure (ALF). This pathway is shown to work as a ...

SURESNES, France, Jan. 27, 2026 /PRNewswire/ -- Servier, an independent international pharmaceutical group governed by a foundation, published its financial results for the 2024/25 financial year ...

As doctors learn why GLP-1s don't work for about 50% of people, they are also learning more about the complex drivers of ...